Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

Abstract Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogeneic bone marrow‐derived mesenchymal stromal cell...

Full description

Bibliographic Details
Main Authors: Erik Boberg, Lena vonBahr, Gabriel Afram, Carina Lindström, Per Ljungman, Nina Heldring, Peter Petzelbauer, Karin Garming Legert, Nadir Kadri, Katarina Le Blanc
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Stem Cells Translational Medicine
Subjects:
cellular therapy
clinical trials
hematopoietic stem cell transplantation
mesenchymal stem cells
thymus
Online Access:https://doi.org/10.1002/sctm.20-0099

Internet

https://doi.org/10.1002/sctm.20-0099

Similar Items